The Global mRNA Treatment Market Size is estimated to be valued at 8.03 billion in 2024 and is predicted to reach 1.05 billion by the year 2031 at a 9.0% CAGR during 2028-2034.
Key Industry Insights & Findings from the Report:
The mRNA Treatment has various advantages, including vaccine preparation. mRNA is the biological preparation that induced active acquired immunity to a particular disease by stimulating the body’s immune system. Moreover, the advancement of lipid nanoparticle formulations for in vivo systemic delivery of mRNA fueling the development of in vivo transfection strategies.
The increasing prevalence of cancer, viral infections, and genetic disorders drive the mRNA treatment market. Additionally, raising awareness about vaccination fueling the global mRNA market. Furthermore, mRNA is being used to produce viral antigen proteins from within the cell are one of the promising therapies for viral disease. For instance, due to the outbreak of COVID-19 number of companies conducting clinical trials for vaccine development is projected to create lucrative opportunities in the near future. North America is dominating the market owing to the presence of key players in the region.
The Global mRNA Treatment market is segmented on the basis of product type, Therapeutic Area, Route of Administration, and region. Based on the product type, the market is divided into mRNA therapeutics and mRNA vaccines. On the basis of Therapeutic Area, the market is divided into Infectious Diseases, Oncological Disorders, Other Disorders. On the basis of Route of Administration, the market is divided into Intravenous, Intramuscular, Intranasal, and Others. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.
|
Report Attribute |
Specifications |
|
Estimated Market Size Value In 2024 |
USD 8.03 Billion |
|
Revenue Forecast In 2031 |
USD 1.05 Billion |
|
Growth Rate CAGR |
CAGR of 9 % from 2028 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2028 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2028-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By Therapeutic Area, By Route of Administration |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
CureVac, Moderna, BioNTech (Pfizer), Translate Bio, Ethris (AstraZeneca), Kernal Biologics, Anima Biotech, H3 Biomedicine Inc., Arcturus Therapeutics, eFFECTOR Therapeutics, Inc., Ionis Pharmaceuticals, Inc., Stemirna Therapeutics Co., Ltd., Skyhawk Therapeutics, Inc., RNAimmune (Sirnaomics), Ziphius Therapeutics NV, miRagen Therapeutics, Inc., Silence Therapeutics, eTheRNA, Tiba Biotechnology, In-Cell-Art, Arcturus Therapeutics among others. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global mRNA Treatment Market Snapshot
Chapter 4. Global mRNA Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Clinical Trial/Pipeline Analysis
4.7. COVID 19 Impact Analysis on Healthcare Industry
Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following Product Type:
5.2.1. mRNA Vaccines
5.2.2. mRNA Therapeutic
Chapter 6. Market Segmentation 2: Therapeutic Area Estimates & Trend Analysis
6.1. Therapeutic Area & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following Therapeutic Area:
6.2.1. Infectious Diseases
6.2.2. Oncological Disorders
6.2.3. Other Disorders
Chapter 7. Market Segmentation 3: Route of Administration Estimates & Trend Analysis
7.1. Route of Administration & Market Share, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following Route of Administration:
7.2.1. Intravenous
7.2.2. Intramuscular
7.2.3. Intranasal
7.2.4. Others
Chapter 8. mRNA Treatment Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by Product Type, 2024-2031
8.1.2. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by Therapeutic Area, 2024-2031
8.1.3. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by Route of Administration, 2024-2031
8.1.4. North America mRNA Treatment Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe mRNA Treatment Market revenue (US$ Million) by Product Type, 2024-2031
8.2.2. Europe mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2024-2031
8.2.3. Europe mRNA Treatment Market revenue (US$ Million) by Route of Administration, 2024-2031
8.2.4. Europe mRNA Treatment Market revenue (US$ Million) by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific mRNA Treatment Market revenue (US$ Million) by Product Type, 2024-2031
8.3.2. Asia Pacific mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2024-2031
8.3.3. Asia Pacific mRNA Treatment Market revenue (US$ Million) by Route of Administration, 2024-2031
8.3.4. Asia Pacific mRNA Treatment Market revenue (US$ Million) by country, 2024-2031
8.4. Latin America
8.4.1. Latin America mRNA Treatment Market revenue (US$ Million) by Product Type, 2024-2031
8.4.2. Latin America mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2024-2031
8.4.3. Latin America mRNA Treatment Market revenue (US$ Million) by Route of Administration, 2024-2031
8.4.4. Latin America mRNA Treatment Market revenue (US$ Million) by country, (US$ Million) 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by Product Type, 2024-2031
8.5.2. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by Therapeutic Area, 2024-2031
8.5.3. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by Route of Administration 2024-2031
8.5.4. Middle East & Africa mRNA Treatment Market revenue (US$ Million) by country, (US$ Million) 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. CureVac
9.2.2. Moderna
9.2.3. BioNTech (Pfizer)
9.2.4. Translate Bio(Sanofi)
9.2.5. Ethris (AstraZeneca)
9.2.6. Kernal Biologics
9.2.7. Silence Therapeutics
9.2.8. eTheRNA (Etherna Immunotherapies)
9.2.9. Tiba Biotechnology
9.2.10. In-Cell-Art
9.2.11. Anima Biotech
9.2.12. H3 Biomedicine Inc.
9.2.13. Arcturus Therapeutics
9.2.14. eFFECTOR Therapeutics, Inc.
9.2.15. Ionis Pharmaceuticals, Inc.
9.2.16. Stemirna Therapeutics Co., Ltd.
9.2.17. Skyhawk Therapeutics, Inc.
9.2.18. RNAimmune (Sirnaomics)
9.2.19. Ziphius Therapeutics NV
9.2.20. miRagen Therapeutics, Inc.
9.2.21. GlaxoSmithKline plc
9.2.22. Other Prominent Players
Global mRNA Treatment Market Revenue (US$ Mn) by Product Type
Global mRNA Treatment Market Revenue (US$ Mn) Based on Therapeutic Area
Global mRNA Treatment Market Revenue (US$ Mn) Based on Route of Administration
Global mRNA Treatment Market Revenue (US$ Mn) Based on Region
Europe mRNA Treatment Market Revenue (US$ Mn) by Country
North America mRNA Treatment Market Revenue (US$ Mn) by Country
Asia Pacific mRNA Treatment Market Revenue (US$ Mn) by Country
Latin America mRNA Treatment Market Revenue (US$ Mn) by Country
Middle East & Africa mRNA Treatment Market Revenue (US$ Mn) by Country
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
